December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News

TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
June 15, 2015 by Chain Drug Review
Daryl Katz, Jürgen Schreiber, Katz Group, Rexall Health, Shoppers Drug Mart
2015, Issue 06-15-2015, News

EDMONTON, Alberta — Canada’s Rexall/Rexall Pharma Plus drug chain has a new chief executive officer and a new operating structure. Former Shoppers Drug Mart chief executive Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Plans call for Schreiber, who joins the company from Edcon Group, South
May 28, 2015 by John Schultz and Chain Drug Review
Claimsecure, Daryl Katz, Edcon Group, Jürgen Schreiber, Katz Group, Medicentres Canada, Rexall, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News

EDMONTON, Alberta – Former Shoppers Drug Mart chief executive officer Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Rexall said Thursday that Schreiber, who joins the company from Edcon Group, South Africa’s largest nonfood retailer, is slated to take the helm as CEO in August. In
January 31, 2012 by Chain Drug Review
Daryl Katz, Dell Pharmacies, Drug Trading Co., John Hammergren, Katz Group Canada, McKesson, Medicine Shoppe Canada, ProPharm, Rexall
Business, Retail News
TORONTO — Katz Group Canada has signed an agreement to sell Drug Trading Co., its banner pharmacy business, and Medicine Shoppe Canada, its franchise pharmacy business, to McKesson Corp. for about $920 million. As part of the transaction McKesson is entering into other ancillary agreements with Katz Group. Both Drug Trading and Medicine Shoppe Canada